How about pharmaceutical companies are not allowed to initiate an interaction with doctors or patients in any way for any reason?
If a doctor/patient has a question they can reach out. If a company has a new treatment they’ll publish findings and doctors in the field will find out through data and not marketing.
I’m on board with that. Though I’d allow them to put out standardized official press releases and catalogs of products. I’d actually prefer the AMA and FDA release catalogs of approved medications if the FDA can be shielded from political interference. As well as having the FDA put out an official summary of a product when they approve it.
Ultimately I do want physicians to be made aware of new medications, and I know they’re already busy. There’s a middle ground between no uninitiated communication and allowing unrestricted freedom to advertise and lie to physicians and patients, claiming things like that oxycontin is nonaddictive.
The problem with the last one is that while the sacklers fucked everyone, I don’t trust politicians when they interfere in medical treatments.
How about pharmaceutical companies are not allowed to initiate an interaction with doctors or patients in any way for any reason?
If a doctor/patient has a question they can reach out. If a company has a new treatment they’ll publish findings and doctors in the field will find out through data and not marketing.
I’m on board with that. Though I’d allow them to put out standardized official press releases and catalogs of products. I’d actually prefer the AMA and FDA release catalogs of approved medications if the FDA can be shielded from political interference. As well as having the FDA put out an official summary of a product when they approve it.
Ultimately I do want physicians to be made aware of new medications, and I know they’re already busy. There’s a middle ground between no uninitiated communication and allowing unrestricted freedom to advertise and lie to physicians and patients, claiming things like that oxycontin is nonaddictive.